NetworkNewsBreaks

TuesdayJun 11, 2024 1:52 pm

NetworkNewsBreaks – Match Group Inc. (NASDAQ: MTCH) Sees Share Price Increase Post-Earnings Report

Match Group (NASDAQ: MTCH), a leading provider of dating products available globally, has experienced a notable 5.4% increase in its share price since its last earnings report a month ago, outpacing the S&P 500. This growth is attributed to the company’s impressive first-quarter earnings for 2024, which saw a 4.8% increase in earnings per share from the previous year to 44 cents, and a 9% rise in revenues year-over-year to $859.65 million. The success of its popular dating apps, Tinder and Hinge, played a significant role in this performance, particularly in the Americas and Europe. Despite the overall positive revenue growth, Match Group faced challenges with a 6% year-over-year…

Continue Reading

TuesdayJun 11, 2024 1:40 pm

NetworkNewsBreaks – GivBux Inc. (GBUX) Moves to Qualify as OTCQB Corporation

GivBux (OTC: GBUX), a publicly traded super app and charitable giving platform, today announced significant progress toward its goal of becoming a fully reporting OTCQB Corporation. “We are happy to report that we have been working diligently on our ‘Promises Made, Promised Kept’ commitment to transparency and accountability to our stakeholders,” said GivBux President Umesh Tim Singh. “We anticipate that our independent auditors will complete their task within the next few weeks, and that we will be filing our SEC Form 10 and all its required documentation shortly thereafter. I am also pleased to report that while these steps are…

Continue Reading

TuesdayJun 11, 2024 1:37 pm

NetworkNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Announces Results of Recent Alzheimer’s Study, Schedules Investor Call

Annovis Bio (NYSE: ANVS), a late-stage, clinical-drug-platform company developing novel therapies for neurodegenerative disorders such as Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), is reporting the results of its recent phase 2/3 Alzheimer’s study. The study was designed to evaluate Buntanetap, the company’s lead drug candidate. According to the report, key findings indicate that Buntanetap showed statistically significant efficacy and safety in the treatment of both carriers and noncarriers of Apolipoprotein E4 (APOE4), a genetic cause of AD. The company has scheduled an investor call for today at 4:30 p.m. ET to provide more detailed information and outline future development plans…

Continue Reading

TuesdayJun 11, 2024 1:30 pm

NetworkNewsBreaks – Bebuzee Inc. (BBUZ) Adds Two Live-Streaming Features to Super App, Enhancing User Engagement and Transforming Experience

Bebuzee (OTC: BBUZ), a leading social media and digital entertainment platform, has unveiled two groundbreaking live-streaming features in its revolutionary super app: TikTok-Style Live Streaming and YouTube Style Live Streaming. According to the announcement, these additions to the app are designed to enhance user engagement and transform the digital experience for Bebuzee users, allowing them to experiment with content and connect with creators and communities in new ways. The TikTok-style live streaming feature offers the ability to broadcast short, engaging live videos in real time, an ideal way to create spontaneous content, live interactions and viral moments. The YouTube-style live…

Continue Reading

TuesdayJun 11, 2024 1:25 pm

NetworkNewsBreaks – SenesTech Inc. (NASDAQ: SNES) to Present at Emerging Growth Conference

SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, is scheduled to present at the 72nd Emerging Growth Conference, hosted by leading independent small cap media portal EmergingGrowth.com. Taking place on June 12 - 13, 2024, the event identifies companies in a wide range of growth sectors with strong management teams, innovative products and services, focused strategy, execution, and the overall potential for long-term growth. Joel L. Fruendt, president, CEO and director of SenesTech is scheduled to provide a keynote speech at the conference starting at 3:20 p.m. ET on June 12. To view the full…

Continue Reading

TuesdayJun 11, 2024 1:14 pm

NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Participation at Upcoming Emerging Growth Conference

InMed Pharmaceuticals (NASDAQ: INM), a clinical-stage pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates, will be featured in this week’s Emerging Growth Conference. The conference is slated for June 12–13, 2024. According to the announcement, InMed Pharmaceuticals CEO Eric A. Adams will be presenting at the two-day event. During his presentation, Adams will provide a corporate overview of the company; the presentation will also include a Q&A session. Adams’ presentation is scheduled to begin at 1:45 p.m. EDT on June 13. An archived replay of the presentation will be available on the InMed Pharmaceuticals website.…

Continue Reading

TuesdayJun 11, 2024 11:03 am

NetworkNewsBreaks – Correlate Energy Corp. (CIPI) Working on $400M ‘Landmark’ Initiative to Develop Nation’s First Microgrid Utility

Correlate Energy (OTCQB: CIPI) is working to develop the first microgrid utility in the country. According to the announcement, the company is partnering with Compass Energy Platform and Distributed Energy Capital (“DEC”) on the landmark initiative, which will be a major advancement in adopting renewable utility infrastructure, ensuring reliable and resilient clean energy. The project is being led by Cuyahoga Green Energy (“CGE”) and will be the first new county utility for Cuyahoga County in more than 75 years. To begin with, the project calls for the development of four microgrids, totaling approximately $400 million, with opportunities for follow-on initiatives.…

Continue Reading

MondayJun 10, 2024 1:36 pm

NetworkNewsBreaks – Dalmore Group Exec Featured Guest in Latest Episode of The Bell2Bell Podcast

Dalmore Group, a tech-driven investment bank and broker dealer on a mission to revolutionize the way companies raise capital online, is spotlighted in the most recent episode of The Bell2Bell Podcast. Released by IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, the Bell2Bell Podcast delivers exclusive interviews with executives and professionals operating in fast-moving industries. During the podcast, Dalmore Group director of sales Stormer Santana and host Jonathan Keim discussed what Santana enjoys most about working in online fundraising, which is the opportunity to interact with hundreds of passionate entrepreneurs. Santana also explained how…

Continue Reading

MondayJun 10, 2024 1:31 pm

NetworkNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Enters Key Northeast Hub with Addition of New England Area Dealer

Mullen Automotive (NASDAQ: MULN), an electric vehicle (“EV”) manufacturer, today announced the addition of zero-emissions commercial vehicle dealership, Eco Auto, a Boston, Massachusetts-area dedicated EV dealer. As Mullen’s newest franchise dealer, Eco Auto will cover national fleet opportunities for the company’s full line of commercial electric vehicles with particular focus on the regional New England area. According to the announcement, Eco Auto’s initial vehicle order includes 10 Mullen ONE, Class 1 EV cargo vans, and 3 Mullen THREE, Class 3 EV cab forward EV trucks. “The New England area is a key Northeast hub for commercial fleet companies and one…

Continue Reading

MondayJun 10, 2024 11:20 am

NetworkNewsBreaks – Software Effective Solutions Corp. (d/b/a MedCana) (SFWJ) Provides Operations, Expansion Update

Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ), a leading entity in the cannabis and agricultural technology sectors, is beginning its first expansion phase and is reporting on its strategic initiative. According to the announcement, through careful and deliberate planning and foresight, MedCana is reporting the allocation of an additional two hectares dedicated to production. Calling the move “pivotal,” the company noted that MedCana management is committed to meeting escalating market demands and fortifying the company’s operational capabilities. In addition, the report noted that MedCana and its majority-held subsidiary, Eko2o S.A.S, have achieved a 35% reduction in construction costs associated…

Continue Reading